|
|
Hepatitis B InfoCenter
http://www.hepnet.com/hepb.html
| |
|
The
Hepatitis
Information Network
Hepatitis B
|
|
Hepatitis B
InfoCenter
THIS PAGE contains links
to a variety of Hepatitis B information and news. This information is
updated periodically. For easier navigation, this page has been subdivided
into Publications, Papers, etc., and
News Reports. All papers are copyright and permission for reproduction
must be granted.
Publications, Papers and Web Sites
December 3, 2000: According to Toronto's Sunday Star,
''Canada, concerned with health risks to its citizens and new demands on its
already fragile Medicare system, plans to screen
would-be immigrants
for HIV and Hepatitis B and deny them entry if they test positive.''
May 14, 2000: Find out more about hepatitis B, what it is,
where it all began and more in
''Hepatitis B: The Complexities'', the first in a series of newsletters
produced by Frank Anderson, M.D., FRCP(C) and his hepatitis team, Natalie
Rock and Susan Campbell.
May 1, 2000:
BioChem Pharma Inc.
announced that new Zeffix data were presented today at the European
Association for the Study of the Liver (EASL) congress, in Rotterdam.
February 2, 2000: A large proportion of the Chinese
migrant boat people
who arrived in British Columbia last summer are chronic carriers of
hepatitis B, the Canadian Medical Association Journal reports.
September 17, 1999: Now you can
view the proceedings
of a consensus conference on the management of viral hepatitis sponsored by
the Canadian Association for Study of the Liver and Health Canada. Topics
include the epidemiology, natural history, and treatment of hepatitis B and
C patients, as well as a myriad of hepatitis related issues and concerns.
July 13, 1999: According to a recent study published in
the July issue of HEPATOLOGY, the monthly peer-reviewed journal of the
American Association for the Study of Liver Diseases (AASLD), Interferon
efficacy can be increased
if treatment is
prolonged beyond standard therapy.
 April 2, 1999:
Dr. Christian
Brechot, Professor Cell Biology/Hepatology, Paris, France, examines
''Specific Immunotherapy for the Control of Hepatitis B Virus
Multiplication''.
February 28, 1999: Learning that you have hepatitis B can
be confusing and frightening. While medical science has made a lot of
progress in learning about hepatitis, doctors still have many questions
about it, and you probably do too. Take some time and go through this
12 part special patient
section and hopefully many of your questions and concerns will be
addressed.
November 15, 1998: Hepatitis B and C in the Chinese
community is a very common problem. Dr. Florence Wong discusses the
current issues and
concerns.
June 22, 1998: What are the effects of interferon-a on
progression of cirrhosis to hepatocellular carcinoma? Just published is a
retrospective cohort study
in the Lancet. This is a very brief slide presentation summarizing the
results of the paper.
June 9, 1998: Dr. Morris Sherman, a Hepatologist
practicing in Toronto, discusses current and
future therapies
for hepatitis B.
Interferon alpha is effective in the treatment of chronic
hepatitis B in adults and is approved for this indication in the United
States and several other countries. Its safety and efficacy has not been as
carefully evaluated in children.
This trial at
several centers in Canada, Europe and the United States examined the use of
interferon alpha in children between the ages of 1 and 17 years with chronic
hepatitis B.
Hepatitis
Vaccination: Questions and Answers.
June 27, 1997 - Universal hepatitis B vaccination in
Taiwan and the incidence of hepatocellular carcinoma in children -
review by Dr. Howard
Worman and
The New
England Journal abstract.
April 1, 1997CMA
Journal-Hepatitis B
What are the issues and controversies in 1997? Find out in
these 25 abstracts presented from an
"Update on Liver Disease &
Hepatitis".
Jan. 16, 1997Transmission
of hepatitis B to patients from four infected surgeons without hepatitis Be
antigen. Summary by Dr. H. Worman
The Clinical
Consequences of Chronic Hepatitis B a very comprehensive August 1996
paper by Dr. Pierre Pare.
Dr. Samuel Lee, (Hepatologist) discusses appropriate
clinical ''Evaluation of
Patients with Hepatitis B'' as an important part of their overall
management.
Hepatitis B
in the Chinese Community a 1996 paper by Dr. Florence Wong. This paper
is also available in
Chinese.
Here are 10
most frequently asked questions about interferon by Vera Simon.
We have had so many questions about
how interferon works, we've
added a whole page explaining the mechanisms of action.
The World Health Organization believes 50% of the world's
population has been infected by hepatitis B! What is
"The Epidemiology of Hepatitis
B in Canada?" an original paper written by Morris Sherman, Hepatologist.
Who are
High risk individuals, and potential candidates for testing?
Long Term
Follow-Up Hepatitis B Study Summary, and the New England Journal's
abstract.
Most frequently asked questions to: Hepatologists,
Gastroenterologists, Family Physicians, Nurses, and Public Health. These
questions have been
submitted with answers from all of these hepatitis specialists.
News Reports
August 23, 2000: This week,
experts recommended
that all babies get the first of their three doses either during the first
week of life or between 1 and 2 months of age.
April 21, 2000:
Liver cells grown in the
lab may help to keep patients with liver disease alive while they wait for a
liver transplant, according to a report presented this week at the
Experimental Biology 2000 meeting.
April 20, 2000: A
hepatitis B outbreak
among patients at six local clinics in the early 1990s was caused by a
technologist and poor infection control practices, a new study says.
April 13, 2000: The number of
new cases of acute
hepatitis B virus (HBV) infection has declined dramatically in the US over
the past decade, according to a report presented this week at the 10th
International Symposium on Viral Hepatitis and Liver Disease.
November 7, 1999:
BioChem Pharma Inc.
announces that important new research on its discovery Zeffix (lamivudine),
presented today at a major liver specialists' congress, may offer some new
options for hepatitis B patients undergoing or awaiting liver transplant.
November 1, 1999: BioChem Pharma Inc. announced today that
approval has been
received from the Department of Health in Taiwan to market Zeffix (lamivudine),
the first effective oral treatment for chronic hepatitis B discovered by
BioChem Pharma and marketed by Glaxo Wellcome.
May 18, 1999: Testifying before a House subcommittee
investigating vaccine safety, federal
officials said the
use of the hepatitis B vaccine has been monitored for 15 years, and it has
not been proven to be the cause of any deaths and is only rarely linked to
serious side effects.
February 18, 1999: A
study now shows a
booster dose is not necessary following hepatitis B vaccination, which
appears to protect against HBV for at least 12 years.
January 25, 1999: The
hepatitis B vaccine
protects children and adults from serious illness and it's a safe vaccine
parents can trust,'' says Acting Health Officer Dr. Maxine Hayes, state
Department of Health.
December 4, 1998: Canadian discovery for the
treatment of
Chronic Hepatitis B is approved in Canada.
Nov. 8, 1998:
New data presented
at the AASLD in Chicago today, demonstrate the potent antiviral activity of
adefovir dipivoxil against the hepatitis B virus (HBV) in chronically
infected patients.
May 29, 1998: SciClone Pharmaceuticals today
announced that
results from the Company's Taiwan phase 3 trial published in Hepatology (May
1998) demonstrate that ZADAXIN(R) thymosin alpha 1 is effective and safe in
the treatment of chronic hepatitis B.
February 27, 1998: The drug interferon can
prevent liver cancer
in patients who develop cirrhosis as a result of infection with the
hepatitis B virus, Japanese researchers report.
In a
rare case, an elementary school teacher has contracted hepatitis B from
a student chronically infected with the virus.
Transmission
of Hepatitis B to Patients from Four Infected Surgeons without Hepatitis B e
Antigen
Half Of
California's Female Prison Inmates Infected With Hepatitis B
"Hepatitis B puts infants at risk".
"Japanese
Hepatitis B Vaccination Program Successful".
|
|
| |
Webmaster@hepnet.com
HepNet developed by Michael Betel, Copyright © 1995-2000 Schering Canada
Inc.
3535 Trans-Canada Highway, Pointe Claire, Quebec H9R 1B4 |
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
|
|
